Status:
RECRUITING
Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Digital Technology
Mobile Application
Eligibility:
FEMALE
18-56 years
Phase:
NA
Brief Summary
Forty percent of people living worldwide with Parkinson's disease (PD) are women. Twenty percent of patients have PD onset under the age of 60 years, a time when women may encounter significant caregi...
Detailed Description
This is a prospective multicentre pilot study of the impact of the menstrual/hormonal cycle on PD symptoms and their treatment in pre-menopausal WwPD based on the remote tracking of PD symptoms and me...
Eligibility Criteria
Inclusion
- Non-menopausal women
- Diagnosis of PD according to the MDS criteria onset of PD symptoms since at least two years before inclusion
- Age 18-56 years
- On stable medication regimen for PD for at least two months without foreseen need to modify it within the next three months
- With and without OCP or intrauterine devices (IUD
Exclusion
- Post-menopausal women with PD
- Any condition that, in the opinion of the investigator, will preclude the participant from successfully or safely completing study procedures (i.e., dementia, severe depression, etc.)
- People not able to give an informed consent.
Key Trial Info
Start Date :
March 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 12 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06582212
Start Date
March 12 2025
End Date
September 12 2027
Last Update
March 25 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
Grenoble, Grenoble, France
2
CHU Nantes Hôpital Laennec
Nantes, France, 44000
3
CHU Rennes -Site Pontchaillou
Rennes, France, 35000
4
Chu Toulouse
Toulouse, France, 31000